Home >> Tag Archives: Epigenomics—

Tag Archives: Epigenomics—

Put It on the Board, 8/16

August 2016—LabCorp will acquire Sequenom; New York ends state PT services; St. Jude lands CAP ISO 15189 accreditation; Epigenomics’ DNA test included in CRC guideline; OSU to deploy Inspirata digital pathology solution; Mindray’s clinical chemistry analyzer cleared; Successful Keytruda trial stopped early; Top court clarifies autopsy’s place in Texas law; EUA for Siemens Zika assay

Read More »

Epigenomics’ DNA test included in CRC guideline

Aug. 2, 2016—Epigenomics, the German-American cancer molecular diagnostics company, announced that the U.S. Preventive Services Task Force has included Epi ProColon in its new recommendation statement for colorectal cancer screening, published in The Journal of American Medical Association (USPSTF et al. 2016;315]23]:2564–2575). The USPSTF is the first American guideline body to recognize this novel colorectal cancer screening test after its ...

Read More »